FindTrial
Sign In

Comparison of two medicines to check their effects on pain after repair of lower jaw breakage.

Triple blind randomised control trial of two different treatment analgesic regimens following open reduction and internal fixation of mandibular fractures.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/02/012260
Enrollment
100
Registered
2018-02-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients who reported with mandibular fracture

Interventions

Intervention1: Group 1: received Piroxicam : Piroxicam is a Non steroidal anti-inflammatory drug Dose-20mg Route-oral twice a day for 5 days Control Intervention1: Group 2: received Tramadol and Para

Sponsors

SDM College of Dental Sciences and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA I, II AND III. Mandibular fractures not associated with any acute infection.

Exclusion criteria

Exclusion criteria: Patient with any systemic illness like cardiologic and neurologic disorders. Patient with pathologic fractures, osteoradionecrosis, strictly non-operable cases and other facial fractures.

Design outcomes

Primary

MeasureTime frame
PainTimepoint: Postoperative day 1 and day 2—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr K Gopalkrishnan

SDM College of Dental Sciences and Hospital

gops15@gmail.com9886329992

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026